GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MAFG | hg19_v2_chr17_-_79885576_79885624, hg19_v2_chr17_-_79881408_79881423 | -0.10 | 1.4e-01 | Click! |
MAFF | hg19_v2_chr22_+_38609538_38609547 | -0.02 | 7.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chrY_+_2709527 Show fit | 36.54 |
ENST00000250784.8
|
ribosomal protein S4, Y-linked 1 |
|
chr11_-_5248294 Show fit | 21.18 |
ENST00000335295.4
|
hemoglobin, beta |
|
chr16_+_31539197 Show fit | 15.78 |
ENST00000564707.1
|
alpha hemoglobin stabilizing protein |
|
chr16_-_25122785 Show fit | 15.35 |
ENST00000563962.1
ENST00000569920.1 |
RP11-449H11.1 |
|
chr5_-_42811986 Show fit | 15.31 |
ENST00000511224.1
ENST00000507920.1 ENST00000510965.1 |
selenoprotein P, plasma, 1 |
|
chrY_+_2709906 Show fit | 15.14 |
ENST00000430575.1
|
ribosomal protein S4, Y-linked 1 |
|
chr5_-_42812143 Show fit | 14.96 |
ENST00000514985.1
|
selenoprotein P, plasma, 1 |
|
chr1_+_22979474 Show fit | 14.69 |
ENST00000509305.1
|
complement component 1, q subcomponent, B chain |
|
chr1_+_22979676 Show fit | 14.44 |
ENST00000432749.2
ENST00000314933.6 |
complement component 1, q subcomponent, B chain |
|
chr9_-_34710066 Show fit | 14.13 |
ENST00000378792.1
ENST00000259607.2 |
chemokine (C-C motif) ligand 21 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 38.9 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.3 | 34.5 | GO:0030449 | regulation of complement activation(GO:0030449) |
1.4 | 28.9 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
5.3 | 21.2 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.1 | 18.1 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
4.7 | 14.1 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) regulation of dendritic cell dendrite assembly(GO:2000547) |
2.3 | 14.1 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 14.0 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
1.1 | 13.4 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 9.7 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 53.9 | GO:0005844 | polysome(GO:0005844) |
0.0 | 29.7 | GO:0005615 | extracellular space(GO:0005615) |
5.8 | 29.1 | GO:0005602 | complement component C1 complex(GO:0005602) |
2.4 | 28.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
5.3 | 21.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 17.3 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 16.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 16.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.3 | 11.8 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 10.5 | GO:0005796 | Golgi lumen(GO:0005796) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.3 | 50.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.6 | 46.8 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 42.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.6 | 24.5 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
1.5 | 20.1 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.2 | 15.1 | GO:0005518 | collagen binding(GO:0005518) |
0.8 | 14.1 | GO:0043295 | glutathione binding(GO:0043295) |
0.4 | 10.9 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 10.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.7 | 9.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 41.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 18.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 15.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 13.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 7.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 6.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 6.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 5.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 5.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 5.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 44.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
2.6 | 29.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.4 | 20.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 15.7 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.2 | 14.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 13.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 11.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 11.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.7 | 11.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.4 | 9.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |